Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $40.1 million.

  • Ironwood Pharmaceuticals' Profit After Tax rose 99928.69% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 101473.89%. This contributed to the annual value of $880000.0 for FY2024, which is 10008.53% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Profit After Tax is $40.1 million, which was up 99928.69% from $23.6 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Profit After Tax ranged from a high of $391.3 million in Q2 2021 and a low of -$1.1 billion during Q2 2023
  • Moreover, its 5-year median value for Profit After Tax was $37.1 million (2022), whereas its average is -$15.8 million.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Profit After Tax tumbled by 303818.23% in 2023 and then skyrocketed by 284406.98% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Profit After Tax (Quarter) stood at $41.4 million in 2021, then increased by 18.11% to $48.9 million in 2022, then tumbled by 103.57% to -$1.7 million in 2023, then soared by 229.28% to $2.3 million in 2024, then soared by 1676.6% to $40.1 million in 2025.
  • Its Profit After Tax was $40.1 million in Q3 2025, compared to $23.6 million in Q2 2025 and -$37.4 million in Q1 2025.